title: POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL.
abstract: OBJECTIVE
  To assess the performance of biochemical markers in the detection of recurrent Cushing disease (CD), as well as the potential benefit of early intervention in recurrent CD patients with elevated late-night salivary cortisol (LNSC) and normal urinary free cortisol (UFC).
  
  
  METHODS
  The design was a single-center, retrospective chart review. Patients treated by the authors from 2008-2013 were included. Recurrence was defined by postsurgical remission of CD with subsequent abnormal LNSC, UFC, or dexamethasone suppression test (DST).
  
  
  RESULTS
  We identified 15 patients with postsurgical recurrent CD after initial remission; all but one underwent testing with LNSC, DST, and UFC. Although 12 of 15 patients had normal UFC at time of recurrence, DST was abnormal in 11 of 15, and all 14 patients with LNSC results had ≥1 elevated measurement. Nine patients (7 with normal UFC) showed radiologic evidence of a pituitary tumor at time of recurrence. Among the 14 patients with available follow-up data, 12 have demonstrated significant improvement since receiving treatment. Five patients underwent repeat pituitary surgery and 4 achieved clinical and biochemical remission. Eight patients received mifepristone or cabergoline, and 6 showed clinical and/or biochemical improvement. Three patients (2 with prior mifepristone) underwent bilateral adrenalectomy and 2 demonstrated significant clinical improvements.
  
  
  CONCLUSIONS
  LNSC is more sensitive than UFC or DST for detection of CD recurrence. Prompt intervention when LNSC is elevated, despite normal UFC, may yield significant clinical benefit for many patients with CD. Early treatment for patients with recurrent CD should be prospectively evaluated, utilizing LNSC elevation as an early biochemical marker.
  
  
  BACKGROUND
  ACTH = adrenocorticotropic hormone CD = Cushing disease CS = Cushing syndrome CV = coefficient of variation DST = dexamethasone suppression test IPSS = inferior petrosal sinus sampling LNSC = late-night salivary cortisol QoL = quality of life TSS = transsphenoidal adenoma resection UFC = urinary free cortisol.
authors.forename: Ty B
authors.initials: TB
authors.lastname: Carroll
authors.forename: Bradley R
authors.initials: BR
authors.lastname: Javorsky
authors.forename: James W
authors.initials: JW
authors.lastname: Findling
mesh_terms: D049913:ACTH-Secreting Pituitary Adenoma / Q000150:complications / Q000473:pathology / Q000601:surgery* / Q000652:urine; D000236:Adenoma / Q000150:complications / Q000473:pathology / Q000601:surgery* / Q000652:urine; D000328:Adult; D000368:Aged; D061345:Early Medical Intervention; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000652:urine*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000601:surgery / Q000652:urine; D047748:Pituitary ACTH Hypersecretion / Q000209:etiology* / Q000473:pathology / Q000601:surgery* / Q000652:urine; D011183:Postoperative Complications / Q000473:pathology / Q000652:urine; D012008:Recurrence; D012189:Retrospective Studies; D018570:Risk Assessment
chemical_list: D006854:Hydrocortisone